• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

伊朗肝脏移植的当前挑战

Current Challenges of Liver Transplantation in Iran.

作者信息

Saidi Reza F, Kazemaini Seyed Mohammad, Malekzadeh Reza

机构信息

Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Liver and Pancreaticobilliary Research Center , Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Middle East J Dig Dis. 2018 Jan;10(1):45-49. doi: 10.15171/mejdd.2017.90. Epub 2018 Jan 11.

DOI:10.15171/mejdd.2017.90
PMID:29682248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5903927/
Abstract

Liver transplantation (LT) is a lifesaving procedure and the treatment of choice for patients suffering from end-stage liver disease (ESLD). There is increasing number of patients with ESLD in Iran. There is a need to expand and develop new centers to provide better access to LT for patients with ESLD in Iran. This review will address current and future challenges for LT in Iran.

摘要

肝移植（LT）是一种挽救生命的手术，也是终末期肝病（ESLD）患者的首选治疗方法。伊朗终末期肝病患者的数量在不断增加。有必要扩大和发展新的中心，以便伊朗的终末期肝病患者能更好地获得肝移植治疗。本综述将探讨伊朗肝移植目前及未来面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/5186d04c8e98/mejdd-10-45-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/f64a899aaea9/mejdd-10-45-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/bad140ddfbba/mejdd-10-45-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/97c963cdb7b1/mejdd-10-45-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/8f2a881a6e9d/mejdd-10-45-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/5186d04c8e98/mejdd-10-45-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/f64a899aaea9/mejdd-10-45-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/bad140ddfbba/mejdd-10-45-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/97c963cdb7b1/mejdd-10-45-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/8f2a881a6e9d/mejdd-10-45-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ad0/5903927/5186d04c8e98/mejdd-10-45-g005.jpg

相似文献

1
Current Challenges of Liver Transplantation in Iran.伊朗肝脏移植的当前挑战
Middle East J Dig Dis. 2018 Jan;10(1):45-49. doi: 10.15171/mejdd.2017.90. Epub 2018 Jan 11.
2
End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.终末期肝病模型（MELD）评分>40的终末期肝病患者与1A类患者相比，等待名单上的死亡率更高。
Hepatol Int. 2016 Sep;10(5):838-46. doi: 10.1007/s12072-016-9735-4. Epub 2016 May 24.
3
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.终末期肝病的内部机制：肝细胞是关键。
Semin Liver Dis. 2021 May;41(2):213-224. doi: 10.1055/s-0041-1725023. Epub 2021 May 15.
4
The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease.肝移植对终末期肝病患者自主神经功能障碍的影响。
Liver Transpl. 2008 Feb;14(2):235-9. doi: 10.1002/lt.21350.
5
Liver Transplantation: East versus West.肝移植：东方与西方
J Clin Exp Hepatol. 2013 Sep;3(3):243-53. doi: 10.1016/j.jceh.2013.08.004. Epub 2013 Sep 12.
6
Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation.在肝移植评估期间使用计算机断层扫描冠状动脉钙化评分进行冠状动脉疾病风险分层
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):319-328. doi: 10.1016/j.jceh.2021.08.015. Epub 2021 Aug 21.
7
Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.酒精性脂肪肝导致终末期肝病患者在肝移植前的冠状动脉粥样硬化特征：一项冠状动脉 CTA 研究。
Eur Radiol. 2021 Jan;31(1):494-503. doi: 10.1007/s00330-020-07037-8. Epub 2020 Aug 4.
8
Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review.等待肝移植的终末期肝病患者的姑息治疗：综述
GE Port J Gastroenterol. 2020 Nov;27(6):417-428. doi: 10.1159/000507336. Epub 2020 May 27.
9
The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review.被拒绝肝移植的肝硬化患者姑息治疗服务的利用情况：单中心回顾性研究
Ann Hepatol. 2017 May-Jun;16(3):395-401. doi: 10.5604/16652681.1235482.
10
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges.干细胞在终末期肝病患者中的临床应用：进展与挑战。
Ann Transl Med. 2020 Apr;8(8):564. doi: 10.21037/atm.2020.03.153.

引用本文的文献

1
Risk factors of the post-reperfusion syndrome during orthotopic liver transplantation: a clinical observational study.原位肝移植术后再灌注综合征的危险因素：一项临床观察性研究。
BMC Anesthesiol. 2022 Apr 2;22(1):89. doi: 10.1186/s12871-022-01635-3.
2
Patients' Experiences of Life Challenges After Liver Transplantation: A Qualitative Study.肝移植后患者应对生活挑战的经历：一项定性研究。
J Patient Exp. 2021 Feb 26;8:2374373521996956. doi: 10.1177/2374373521996956. eCollection 2021.
3
The Situation of Liver Transplantation Programs in Iran.

本文引用的文献

1
Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden.伊朗丙型肝炎病毒感染的肝脏疾病负担以及各种治疗策略对疾病负担的潜在影响。
Hepat Mon. 2016 Jun 14;16(7):e37234. doi: 10.5812/hepatmon.37234. eCollection 2016 Jul.
2
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担：全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
3
Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran.
伊朗肝脏移植项目的情况
Middle East J Dig Dis. 2018 Jul;10(3):194-195. doi: 10.15171/mejdd.2018.111. Epub 2018 Jun 24.
一个中等收入国家炎症性肠病的新发病例：来自伊朗的全国性研究。
Arch Iran Med. 2016 Jan;19(1):2-15.
4
Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010.伊朗胃肠道和肝脏疾病负担：基于《2010年全球疾病、伤害和风险因素负担研究》的估计
Middle East J Dig Dis. 2015 Jul;7:138-54.
5
Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010.伊朗胃肠道和肝脏疾病的趋势：2010年全球疾病负担研究结果
Middle East J Dig Dis. 2015 Jul;7:121-37.
6
Common Digestive and Liver Diseases among 5880 Patients Admitted to Shariati Hospital,Tehran,Iran during 2000-2009.2000年至2009年期间伊朗德黑兰沙里亚蒂医院收治的5880例患者中的常见消化和肝脏疾病
Middle East J Dig Dis. 2012 Jan;4(1):28-33.
7
Establishing a liver transplantation program at Tehran University of Medical Sciences, Iran: a report of ten years of experience.在伊朗德黑兰医科大学建立肝脏移植项目：十年经验报告。
Arch Iran Med. 2014 Jan;17(1):81-3.
8
Causes of family refusal for organ donation.家庭拒绝器官捐赠的原因。
Transplant Proc. 2011 Mar;43(2):405-6. doi: 10.1016/j.transproceed.2011.01.031.
9
Organ retrieval from brain-dead patients by a single organ procurement center in Iran.伊朗一个单一器官获取中心从脑死亡患者身上摘取器官。
Transplant Proc. 2009 Sep;41(7):2723-5. doi: 10.1016/j.transproceed.2009.06.145.
10
Transplantation activities in Iran.伊朗的移植活动。
Exp Clin Transplant. 2005 Jun;3(1):333-7.